Global and Japan Hypertension Drug Market Insights, Forecast to 2027

Global and Japan Hypertension Drug Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Hypertension Drug Product Introduction
1.2 Market by Type
1.2.1 Global Hypertension Drug Market Size Growth Rate by Type
1.2.2 Calcium Channel Blockers
1.2.3 Diuretics
1.2.4 Beta Blockers Vasodilators
1.2.5 Angiotensin Converting Enzyme Inhibitors
1.2.6 Alpha Blockers
1.2.7 Angiotensin Receptor Blockers
1.2.8 Renin Inhibitors
1.3 Market by Application
1.3.1 Global Hypertension Drug Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Private Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hypertension Drug Market Size, Estimates and Forecasts
2.1.1 Global Hypertension Drug Revenue 2016-2027
2.1.2 Global Hypertension Drug Sales 2016-2027
2.2 Global Hypertension Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hypertension Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Hypertension Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hypertension Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hypertension Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hypertension Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Hypertension Drug Revenue Forecast by Region (2022-2027)
3 Global Hypertension Drug Competitor Landscape by Players
3.1 Global Top Hypertension Drug Manufacturers by Sales
3.1.1 Global Hypertension Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Hypertension Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hypertension Drug Manufacturers by Revenue
3.2.1 Key Hypertension Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hypertension Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Hypertension Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hypertension Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hypertension Drug Revenue in 2020
3.2.6 Global Hypertension Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hypertension Drug Price by Manufacturers
3.4 Global Hypertension Drug Manufacturing Base Distribution, Product Types
3.4.1 Hypertension Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hypertension Drug Product Type
3.4.3 Date of International Manufacturers Enter into Hypertension Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hypertension Drug Market Size by Type (2016-2021)
4.1.1 Global Hypertension Drug Sales by Type (2016-2021)
4.1.2 Global Hypertension Drug Revenue by Type (2016-2021)
4.1.3 Hypertension Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hypertension Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Hypertension Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Hypertension Drug Revenue Forecast by Type (2022-2027)
4.2.3 Hypertension Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hypertension Drug Market Size by Application (2016-2021)
5.1.1 Global Hypertension Drug Sales by Application (2016-2021)
5.1.2 Global Hypertension Drug Revenue by Application (2016-2021)
5.1.3 Hypertension Drug Price by Application (2016-2021)
5.2 Hypertension Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Hypertension Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Hypertension Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Hypertension Drug Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Hypertension Drug Market Size YoY Growth 2016-2027
6.1.1 Japan Hypertension Drug Sales YoY Growth 2016-2027
6.1.2 Japan Hypertension Drug Revenue YoY Growth 2016-2027
6.1.3 Japan Hypertension Drug Market Share in Global Market 2016-2027
6.2 Japan Hypertension Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Hypertension Drug Players by Sales (2016-2021)
6.2.2 Japan Top Hypertension Drug Players by Revenue (2016-2021)
6.3 Japan Hypertension Drug Historic Market Review by Type (2016-2021)
6.3.1 Japan Hypertension Drug Sales Market Share by Type (2016-2021)
6.3.2 Japan Hypertension Drug Revenue Market Share by Type (2016-2021)
6.3.3 Japan Hypertension Drug Price by Type (2016-2021)
6.4 Japan Hypertension Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Hypertension Drug Sales Forecast by Type (2022-2027)
6.4.2 Japan Hypertension Drug Revenue Forecast by Type (2022-2027)
6.4.3 Japan Hypertension Drug Price Forecast by Type (2022-2027)
6.5 Japan Hypertension Drug Historic Market Review by Application (2016-2021)
6.5.1 Japan Hypertension Drug Sales Market Share by Application (2016-2021)
6.5.2 Japan Hypertension Drug Revenue Market Share by Application (2016-2021)
6.5.3 Japan Hypertension Drug Price by Application (2016-2021)
6.6 Japan Hypertension Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Hypertension Drug Sales Forecast by Application (2022-2027)
6.6.2 Japan Hypertension Drug Revenue Forecast by Application (2022-2027)
6.6.3 Japan Hypertension Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hypertension Drug Market Size YoY Growth 2016-2027
7.2 North America Hypertension Drug Market Facts & Figures by Country
7.2.1 North America Hypertension Drug Sales by Country (2016-2021)
7.2.2 North America Hypertension Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hypertension Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hypertension Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Hypertension Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Hypertension Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Hypertension Drug Market Size YoY Growth 2016-2027
9.2 Europe Hypertension Drug Market Facts & Figures by Country
9.2.1 Europe Hypertension Drug Sales by Country (2016-2021)
9.2.2 Europe Hypertension Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hypertension Drug Market Size YoY Growth 2016-2027
10.2 Latin America Hypertension Drug Market Facts & Figures by Country
10.2.1 Latin America Hypertension Drug Sales by Country (2016-2021)
10.2.2 Latin America Hypertension Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hypertension Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hypertension Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Hypertension Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hypertension Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Lupin Limited
12.1.1 Lupin Limited Corporation Information
12.1.2 Lupin Limited Description and Business Overview
12.1.3 Lupin Limited Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Lupin Limited Hypertension Drug Products Offered
12.1.5 Lupin Limited Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Corporation Information
12.2.2 Novartis AG Description and Business Overview
12.2.3 Novartis AG Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis AG Hypertension Drug Products Offered
12.2.5 Novartis AG Recent Development
12.3 Daiichi - Sankyo
12.3.1 Daiichi - Sankyo Corporation Information
12.3.2 Daiichi - Sankyo Description and Business Overview
12.3.3 Daiichi - Sankyo Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Daiichi - Sankyo Hypertension Drug Products Offered
12.3.5 Daiichi - Sankyo Recent Development
12.4 Pfizer Inc
12.4.1 Pfizer Inc Corporation Information
12.4.2 Pfizer Inc Description and Business Overview
12.4.3 Pfizer Inc Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Inc Hypertension Drug Products Offered
12.4.5 Pfizer Inc Recent Development
12.5 Ranbaxy Laboratories Limited
12.5.1 Ranbaxy Laboratories Limited Corporation Information
12.5.2 Ranbaxy Laboratories Limited Description and Business Overview
12.5.3 Ranbaxy Laboratories Limited Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ranbaxy Laboratories Limited Hypertension Drug Products Offered
12.5.5 Ranbaxy Laboratories Limited Recent Development
12.6 Sanofi S.A
12.6.1 Sanofi S.A Corporation Information
12.6.2 Sanofi S.A Description and Business Overview
12.6.3 Sanofi S.A Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanofi S.A Hypertension Drug Products Offered
12.6.5 Sanofi S.A Recent Development
12.7 AstraZeneca Plc
12.7.1 AstraZeneca Plc Corporation Information
12.7.2 AstraZeneca Plc Description and Business Overview
12.7.3 AstraZeneca Plc Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 AstraZeneca Plc Hypertension Drug Products Offered
12.7.5 AstraZeneca Plc Recent Development
12.8 Johnson & Johnson Ltd
12.8.1 Johnson & Johnson Ltd Corporation Information
12.8.2 Johnson & Johnson Ltd Description and Business Overview
12.8.3 Johnson & Johnson Ltd Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Johnson & Johnson Ltd Hypertension Drug Products Offered
12.8.5 Johnson & Johnson Ltd Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Corporation Information
12.9.2 Boehringer Ingelheim Description and Business Overview
12.9.3 Boehringer Ingelheim Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Boehringer Ingelheim Hypertension Drug Products Offered
12.9.5 Boehringer Ingelheim Recent Development
12.10 Merck & Co.
12.10.1 Merck & Co. Corporation Information
12.10.2 Merck & Co. Description and Business Overview
12.10.3 Merck & Co. Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck & Co. Hypertension Drug Products Offered
12.10.5 Merck & Co. Recent Development
12.11 Lupin Limited
12.11.1 Lupin Limited Corporation Information
12.11.2 Lupin Limited Description and Business Overview
12.11.3 Lupin Limited Hypertension Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lupin Limited Hypertension Drug Products Offered
12.11.5 Lupin Limited Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hypertension Drug Industry Trends
13.2 Hypertension Drug Market Drivers
13.3 Hypertension Drug Market Challenges
13.4 Hypertension Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hypertension Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Hypertension Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Calcium Channel Blockers
Table 3. Major Manufacturers of Diuretics
Table 4. Major Manufacturers of Beta Blockers Vasodilators
Table 5. Major Manufacturers of Angiotensin Converting Enzyme Inhibitors
Table 6. Major Manufacturers of Alpha Blockers
Table 7. Major Manufacturers of Angiotensin Receptor Blockers
Table 8. Major Manufacturers of Renin Inhibitors
Table 9. Global Hypertension Drug Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 10. Global Hypertension Drug Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 11. Global Hypertension Drug Sales by Regions (2016-2021) & (K Units)
Table 12. Global Hypertension Drug Sales Market Share by Regions (2016-2021)
Table 13. Global Hypertension Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 14. Global Hypertension Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 15. Global Hypertension Drug Sales Market Share Forecast by Region (2022-2027)
Table 16. Global Hypertension Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 17. Global Hypertension Drug Revenue Market Share Forecast by Region (2022-2027)
Table 18. Global Hypertension Drug Sales by Manufacturers (2016-2021) (K Units)
Table 19. Global Hypertension Drug Sales Share by Manufacturers (2016-2021)
Table 20. Ranking of Global Top Hypertension Drug Manufacturers by Revenue (US$ Million) in 2020
Table 21. Hypertension Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 22. Hypertension Drug Revenue Share by Manufacturers (2016-2021)
Table 23. Global Hypertension Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 24. Global Hypertension Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypertension Drug as of 2020)
Table 25. Key Manufacturers Hypertension Drug Price (2016-2021) (USD/Unit)
Table 26. Hypertension Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Hypertension Drug Product Type
Table 28. Date of International Manufacturers Enter into Hypertension Drug Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Hypertension Drug Sales by Type (2016-2021) (K Units)
Table 31. Global Hypertension Drug Sales Share by Type (2016-2021)
Table 32. Global Hypertension Drug Revenue by Type (2016-2021) (US$ Million)
Table 33. Global Hypertension Drug Revenue Share by Type (2016-2021)
Table 34. Hypertension Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 35. Global Hypertension Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 36. Global Hypertension Drug Sales Market Share Forecast by Type (2022-2027)
Table 37. Global Hypertension Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 38. Global Hypertension Drug Revenue Market Share Forecast by Type (2022-2027)
Table 39. Global Hypertension Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 40. Global Hypertension Drug Sales by Application (2016-2021) (K Units)
Table 41. Global Hypertension Drug Sales Share by Application (2016-2021)
Table 42. Global Hypertension Drug Revenue by Application (2016-2021) (US$ Million)
Table 43. Global Hypertension Drug Revenue Share by Application (2016-2021)
Table 44. Hypertension Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 45. Global Hypertension Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 46. Global Hypertension Drug Sales Market Share Forecast by Application (2022-2027)
Table 47. Global Hypertension Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 48. Global Hypertension Drug Revenue Market Share Forecast by Application (2022-2027)
Table 49. Global Hypertension Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 50. Japan Hypertension Drug Sales (K Units) of Key Companies (2016-2021)
Table 51. Japan Hypertension Drug Sales Share by Company (2016-2021)
Table 52. Japan Hypertension Drug Revenue (US$ Million) by Company (2016-2021)
Table 53. Japan Hypertension Drug Revenue Share by Company (2016-2021)
Table 54. Japan Hypertension Drug Sales (K Units) by Type (2016-2021)
Table 55. Japan Hypertension Drug Sales Share by Type (2016-2021)
Table 56. Japan Hypertension Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 57. Japan Hypertension Drug Price (USD/Unit) by Type (2016-2021)
Table 58. Japan Hypertension Drug Sales (K Units) by Type (2022-2027)
Table 59. Japan Hypertension Drug Sales Share by Type (2022-2027)
Table 60. Japan Hypertension Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 61. Japan Hypertension Drug Revenue Share by Type (2022-2027)
Table 62. Japan Hypertension Drug Price (USD/Unit) by Type (2022-2027)
Table 63. Japan Hypertension Drug Sales (K Units) by Application (2016-2021)
Table 64. Japan Hypertension Drug Sales Share by Application (2016-2021)
Table 65. Japan Hypertension Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 66. Japan Hypertension Drug Price (USD/Unit) by Application (2016-2021)
Table 67. Japan Hypertension Drug Sales (K Units) by Application (2022-2027)
Table 68. Japan Hypertension Drug Sales Share by Application (2022-2027)
Table 69. Japan Hypertension Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 70. Japan Hypertension Drug Revenue Share by Application (2022-2027)
Table 71. Japan Hypertension Drug Price (USD/Unit) by Application (2022-2027)
Table 72. North America Hypertension Drug Sales by Country (2016-2021) & (K Units)
Table 73. North America Hypertension Drug Sales Market Share by Country (2016-2021)
Table 74. North America Hypertension Drug Revenue by Country (2016-2021) & (US$ Million)
Table 75. North America Hypertension Drug Revenue Market Share by Country (2016-2021)
Table 76. Asia Pacific Hypertension Drug Sales by Region (2016-2021) & (K Units)
Table 77. Asia Pacific Hypertension Drug Sales Market Share by Region (2016-2021)
Table 78. Asia Pacific Hypertension Drug Revenue by Region (2016-2021) & (US$ Million)
Table 79. Asia Pacific Hypertension Drug Revenue Market Share by Region (2016-2021)
Table 80. Europe Hypertension Drug Sales by Country (2016-2021) & (K Units)
Table 81. Europe Hypertension Drug Sales Market Share by Country (2016-2021)
Table 82. Europe Hypertension Drug Revenue by Country (2016-2021) & (US$ Million)
Table 83. Europe Hypertension Drug Revenue Market Share by Country (2016-2021)
Table 84. Latin America Hypertension Drug Sales by Country (2016-2021) & (K Units)
Table 85. Latin America Hypertension Drug Sales Market Share by Country (2016-2021)
Table 86. Latin Americaa Hypertension Drug Revenue by Country (2016-2021) & (US$ Million)
Table 87. Latin America Hypertension Drug Revenue Market Share by Country (2016-2021)
Table 88. Middle East and Africa Hypertension Drug Sales by Country (2016-2021) & (K Units)
Table 89. Middle East and Africa Hypertension Drug Sales Market Share by Country (2016-2021)
Table 90. Middle East and Africa Hypertension Drug Revenue by Country (2016-2021) & (US$ Million)
Table 91. Middle East and Africa Hypertension Drug Revenue Market Share by Country (2016-2021)
Table 92. Lupin Limited Corporation Information
Table 93. Lupin Limited Description and Business Overview
Table 94. Lupin Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Lupin Limited Hypertension Drug Product
Table 96. Lupin Limited Recent Development
Table 97. Novartis AG Corporation Information
Table 98. Novartis AG Description and Business Overview
Table 99. Novartis AG Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Novartis AG Product
Table 101. Novartis AG Recent Development
Table 102. Daiichi - Sankyo Corporation Information
Table 103. Daiichi - Sankyo Description and Business Overview
Table 104. Daiichi - Sankyo Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Daiichi - Sankyo Product
Table 106. Daiichi - Sankyo Recent Development
Table 107. Pfizer Inc Corporation Information
Table 108. Pfizer Inc Description and Business Overview
Table 109. Pfizer Inc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Pfizer Inc Product
Table 111. Pfizer Inc Recent Development
Table 112. Ranbaxy Laboratories Limited Corporation Information
Table 113. Ranbaxy Laboratories Limited Description and Business Overview
Table 114. Ranbaxy Laboratories Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Ranbaxy Laboratories Limited Product
Table 116. Ranbaxy Laboratories Limited Recent Development
Table 117. Sanofi S.A Corporation Information
Table 118. Sanofi S.A Description and Business Overview
Table 119. Sanofi S.A Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Sanofi S.A Product
Table 121. Sanofi S.A Recent Development
Table 122. AstraZeneca Plc Corporation Information
Table 123. AstraZeneca Plc Description and Business Overview
Table 124. AstraZeneca Plc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. AstraZeneca Plc Product
Table 126. AstraZeneca Plc Recent Development
Table 127. Johnson & Johnson Ltd Corporation Information
Table 128. Johnson & Johnson Ltd Description and Business Overview
Table 129. Johnson & Johnson Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Johnson & Johnson Ltd Product
Table 131. Johnson & Johnson Ltd Recent Development
Table 132. Boehringer Ingelheim Corporation Information
Table 133. Boehringer Ingelheim Description and Business Overview
Table 134. Boehringer Ingelheim Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Boehringer Ingelheim Product
Table 136. Boehringer Ingelheim Recent Development
Table 137. Merck & Co. Corporation Information
Table 138. Merck & Co. Description and Business Overview
Table 139. Merck & Co. Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Merck & Co. Product
Table 141. Merck & Co. Recent Development
Table 142. Hypertension Drug Market Trends
Table 143. Hypertension Drug Market Drivers
Table 144. Hypertension Drug Market Challenges
Table 145. Hypertension Drug Market Restraints
Table 146. Hypertension Drug Customers List
Table 147. Hypertension Drug Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypertension Drug Product Picture
Figure 2. Global Hypertension Drug Sales Market Share by Type in 2020 & 2027
Figure 3. Calcium Channel Blockers Product Picture
Figure 4. Diuretics Product Picture
Figure 5. Beta Blockers Vasodilators Product Picture
Figure 6. Angiotensin Converting Enzyme Inhibitors Product Picture
Figure 7. Alpha Blockers Product Picture
Figure 8. Angiotensin Receptor Blockers Product Picture
Figure 9. Renin Inhibitors Product Picture
Figure 10. Global Hypertension Drug Sales Market Share by Application in 2020 & 2027
Figure 11. Hospital
Figure 12. Private Clinic
Figure 13. Others
Figure 14. Hypertension Drug Report Years Considered
Figure 15. Global Hypertension Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Hypertension Drug Market Size 2016-2027 (US$ Million)
Figure 17. Global Hypertension Drug Sales 2016-2027 (K Units)
Figure 18. Global Hypertension Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Hypertension Drug Sales Market Share by Region (2016-2021)
Figure 20. Global Hypertension Drug Sales Market Share by Region in 2020
Figure 21. Global Hypertension Drug Revenue Market Share by Region (2016-2021)
Figure 22. Global Hypertension Drug Revenue Market Share by Region in 2020
Figure 23. Global Hypertension Drug Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Hypertension Drug Revenue in 2020
Figure 25. Hypertension Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Hypertension Drug Sales Market Share by Type (2016-2021)
Figure 27. Global Hypertension Drug Sales Market Share by Type in 2020
Figure 28. Global Hypertension Drug Revenue Market Share by Type (2016-2021)
Figure 29. Global Hypertension Drug Revenue Market Share by Type in 2020
Figure 30. Global Hypertension Drug Sales Market Share by Application (2016-2021)
Figure 31. Global Hypertension Drug Sales Market Share by Application in 2020
Figure 32. Global Hypertension Drug Revenue Market Share by Application (2016-2021)
Figure 33. Global Hypertension Drug Revenue Market Share by Application in 2020
Figure 34. Japan Hypertension Drug Sales Growth Rate 2016-2027 (K Units)
Figure 35. Japan Hypertension Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. Japan Hypertension Drug Market Share in Global Market 2016-2027
Figure 37. Japan 5 and 10 Largest Hypertension Drug Players Market Share by Revenue in Hypertension Drug in 2020
Figure 38. Japan Hypertension Drug Revenue Share by Type (2016-2021)
Figure 39. Japan Hypertension Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 40. Japan Hypertension Drug Revenue Share by Application (2016-2021)
Figure 41. Japan Hypertension Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Hypertension Drug Sales Growth Rate 2016-2021 (K Units)
Figure 43. North America Hypertension Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Hypertension Drug Sales Market Share by Country in 2020
Figure 45. North America Hypertension Drug Revenue Market Share by Country in 2020
Figure 46. U.S. Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 47. U.S. Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 49. Canada Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Hypertension Drug Sales Growth Rate 2016-2021 (K Units)
Figure 51. Europe Hypertension Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Hypertension Drug Sales Market Share by Country in 2020
Figure 53. Europe Hypertension Drug Revenue Market Share by Country in 2020
Figure 54. Germany Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 55. Germany Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 57. France Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 59. U.K. Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 61. Italy Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 63. Russia Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Hypertension Drug Sales Growth Rate 2016-2021 (K Units)
Figure 65. Asia Pacific Hypertension Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Hypertension Drug Sales Market Share by Region in 2020
Figure 67. Asia Pacific Hypertension Drug Revenue Market Share by Region in 2020
Figure 68. China Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 69. China Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 71. Japan Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 73. South Korea Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 75. India Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 77. Australia Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Taiwan Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 79. Taiwan Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 81. Indonesia Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 83. Thailand Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 85. Malaysia Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Philippines Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 87. Philippines Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Vietnam Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 89. Vietnam Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Latin America Hypertension Drug Sales Growth Rate 2016-2021 (K Units)
Figure 91. Latin America Hypertension Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Latin America Hypertension Drug Sales Market Share by Country in 2020
Figure 93. Latin America Hypertension Drug Revenue Market Share by Country in 2020
Figure 94. Mexico Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 95. Mexico Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Brazil Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 97. Brazil Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Argentina Hypertension Drug Sales Growth Rate (2016-2021) (K Units)
Figure 99. Argentina Hypertension Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Middle East and Africa Hypertension Drug Sales Growth Rate 2016-2021 (K Units)
Figure 101. Middle East and Africa Hypertension Drug Revenue Growth Rate 2016-2021 (US$ Million

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs